Colorado info
Nebraska
Kansas info
Maryland info
florida info
Dr. Jonathan Jassey, DO, FAAP Concierge Pediatrics 1520 Old Northern Blvd, Rosyln, NY 11576 (516)514-7337 www.myconciergepediatrics.com Dr. Sharon Semekh Concierge Pediatrics 1520 Old Northern Blvd, Rosyln, NY 11576 (516)514-7337 www.myconciergepediatrics.com
https://cognoa-staging.com/wp-content/uploads/2023/06/CanvasDx_IndicationsforUse.pdf
https://www.contemporarypediatrics.com/view/rise-in-autism-prevalence-highlights-continued-need-for-early-intervention Contemporary Pediatrics®: Hello and thank you for joining us. I’m Joshua Fitch, editor with Contemporary Pediatrics®. J. Thomas Megerian, MD, PhD, FAAP: Hi, I’m Tom Megerian, Joshua. I am Clinical Director at the Thompson Center for Autism and Neurodevelopmental Disorders at Children’s Health...
https://www.newsweek.com/autistic-woman-shares-6-surprising-signs-usually-ignored-girls-1795838
https://healthnews.com/news/scott-steindorff-speaks-out-about-autism-debate/
https://medcitynews.com/2023/02/health-transformation-alliance-teams-up-with-cognoa-for-autism-diagnostic-device/
https://www.prnewswire.com/il/news-releases/cognoa-and-health-transformation-alliance-partner-to-provide-access-to-child-health-solution-canvas-dx-for-self-insured-employers-301748831.html Nearly 60 of America’s leading employers will now be able to offer their employees with children access to Canvas Dx™, the first FDA-authorized diagnostic device for autism in young children – Health Transformation Alliance (HTA), a...
https://ssistrategy.com/podcast/episode-9 As everyday consumers, we interact with AI (Artificial Intelligence) daily. Whether unlocking the home screen of our phones via facial recognition, using voice commands to send a text, or interacting with a chat tool when shopping online, AI adoption is continuous. But what...
https://www.prnewswire.com/il/news-releases/cognoa-to-participate-in-btig-digital-health-forum-301680076.html – Cognoa, a leading pediatric behavioral health company, today announced that Sharief Taraman, MD, DABPN, DABPM, FAAP, Chief Executive Officer of Cognoa, will participate in the opening analyst-led fireside chat at the BTIG Digital Health Forum...
https://www.prnewswire.com/news-releases/cognoa-appoints-pediatric-neurologist-and-ai-in-healthcare-pioneer-dr-sharief-taraman-as-ceo-to-spearhead-the-next-stage-of-the-companys-growth-301677002.html Cognoa is on track for U.S. commercialization of Canvas Dx in 2023 as the first FDA authorized diagnostic device for early and equitable diagnosis of autism in young children – Cognoa, a pediatric behavioral health company,...
https://www.prnewswire.com/news-releases/cognoa-announces-poster-presentations-at-the-2022-american-academy-of-pediatrics-aap-national-conference-and-exhibition-301642639.html – Cognoa, a pediatric behavioral health company, today announced that the Company will be participating in the 2022 American Academy of Pediatrics (AAP) National Conference and Exhibition, taking place October 7 – 11, 2022, at the...
https://digitalhealthtoday.com/episodes/digital-therapeutics-podcast/ep35-diagnosing-autism-spectrum-disorder-with-dtx-dennis-wall-provides-insights-into-canvas-dx/ Digital Health Today’s Podcast with Dennis Wall In this episode we jump back into interviewing some of the early trailblazers and speak with Dennis Wall, Founder of Cognoa. ->Listen Now<- In their owns words, “Cognoa is a pediatric behavioral health company developing...
https://cognoa-staging.com/wp-content/uploads/6_Things_Ive_Learned_From_Children_And_Families_Living_With_Autism-June2022.pdf
6_Things_Ive_Learned_From_Children_And_Families_Living_With_Autism-June2022
https://www.prnewswire.com/news-releases/echo-autism-communities-collaborate-with-cognoa-to-study-real-world-application-of-canvas-dx-301558915.html – Cognoa, a pediatric behavioral health company, is announcing the initiation of a real-world evidence study of its novel AI-based software as a medical device, Canvas Dx, in collaboration with the University of Missouri (MU) ECHO Autism...
https://www.globenewswire.com/news-release/2018/08/27/1557135/0/en/Cognoa-Demonstrates-Advances-of-its-AI-Based-Technology-for-Identifying-Autism-in-Children.htmlPalo Alto, Calif, May 5, 2022 – Cognoa, a pediatric behavioral health company, today announced that npj Digital Medicine, a Nature Portfolio journal, has published data from its pivotal study of the company’s AI-based diagnosis aid for autism spectrum disorder (ASD), Canvas Dx™. Canvas...
https://www.forbes.com/sites/jenniferpalumbo/2022/04/25/why-an-autism-diagnosis-is-not-a-label-but-a-roadmap/?sh=570a3c4851ee
https://www.forbes.com/sites/jenniferpalumbo/2022/04/25/why-an-autism-diagnosis-is-not-a-label-but-a-roadmap/?sh=796f2b7a51ee
https://www.aan.com/events/2022-annual-meetingPalo Alto, Calif, April 4, 2022 – Cognoa, a pediatric behavioral health company, today announced it will be presenting and exhibiting at the 2022 American Academy of Neurology (AAN) Annual Meeting, which will be held April 2 – 7, 2022 in Seattle, Washington. The...
https://www.fiercebiotech.com/special-reports/fierce-medtechs-2021-fierce-15#new_tab
https://www.fiercebiotech.com/medtech/fierce-medtechs-2022-fierce-15Palo Alto, CA – March 7, 2022 – Cognoa, a leading pediatric behavioral health company, today announced that it has been named by Fierce Medtech as one of 2021’s Fierce 15 med tech companies, designating it as one of the most promising private med...
https://www.forbes.com/sites/marijabutkovic/2022/02/14/healthcare-industry-still-lacks-inclusivity-and-accessibility-these-7-female-leaders-are-here-to-change-that/?sh=2fa4c0b37a61#new_tab
https://alldus.com/podcast/ai-in-action-e286-dennis-wall-founder-at-cognoa/#new_tab
https://www.psychiatrictimes.com/view/facilitating-autism-diagnosis#new_tab
https://www.contemporarypediatrics.com/view/ai-telehealth-and-sensor-based-technologies-facilitate-autism-diagnosis#new_tab
Rimac joins Cognoa to provide financial and strategic leadership, bringing over 30 years of broad operating and finance experience within the pharmaceutical, medical device, biotechnology, and drug delivery industries
https://www.youtube.com/watch?v=3ZF-kJSWqUE#new_tabHalim looks at how you can use data in the healthcare space.
https://medtech.pharmaintelligence.informa.com/MT144425/Expert-AIML-Pediatric-Software-Brings-Hope–But-Also-Potential–To-Magnifying-Disparities#new_tab
https://ai-med.io/real-life/ai-driven-autism-diagnosis-aid-receives-fda-authorization/#new_tab
https://medical-technology.nridigital.com/medical_technology_aug21/cognoa_ai_disparities_medicine
https://www.autismparentingmagazine.com/ai-technology-disparities-diagnosis-autism/#new_tab
https://www.unite.ai/halim-abbas-chief-ai-officer-at-cognoa-interview-series/#new_tab
https://www.prnewswire.com/news-releases/cognoa-receives-fda-marketing-authorization-for-first-of-its-kind-autism-diagnosis-aid-301304351.htmlCognoa’s AI-driven device is the first FDA-authorized diagnosis aid designed to help primary care physicians diagnose autism in young children with the goal of shortening time-to-diagnosis and enabling initiation of earlier interventions (Palo Alto, Calif. – June 2nd, 2021) – Cognoa, a pediatric behavioral...
https://reader.mediawiremobile.com/epmagazine/issues/207141/viewer?page=36#new_tab
By: Lani Hessen, Director of Advocacy, Cognoa, and Pediatric Occupational Therapist (OTR/L) Autism impacts an estimated 1 in 54 children in the U.S. today. Autism is a spectrum, representing a tremendous range of skills and challenges spanning learning and communication, socialization and developmental behaviors. ...
https://bhbusiness.com/2021/04/06/how-cognoa-aims-to-revolutionize-the-autism-diagnosis-process/#new_tab
https://apmagpdf.s3.amazonaws.com/Issue_118_Reframing_Education_In_The_New_Normal_5254.pdf#new_tab By David Happel This article was originally published in Autism Parenting Magazine, Issue 118. Nearly 80 years after psychiatrist Leo Kanner became the first physician to use the term “autism”, children and families with autism still face critical gaps and unnecessary delays on their way to...
https://ai-med.io/special-report-neurosciences-mental-health/neuroscience-the-next-ai-frontier/#new_tab
https://www.prnewswire.com/news-releases/cognoa-appoints-industry-veteran-eric-b-mosbrooker-as-chief-operations-officer-301208688.htmlMosbrooker will be leading the operational and commercial efforts of Cognoa’s digital behavioral health products (Palo Alto, Calif. – January 14, 2021) – Cognoa, the leading pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with autism and other behavioral health...
https://medium.com/authority-magazine/meet-the-disruptors-david-happel-of-cognoa-on-the-three-things-you-need-to-shake-up-your-industry-a7b69f0c172e#new_tab
https://www.scarymommy.com/what-to-do-suspect-child-autism
https://www.scarymommy.com/what-to-do-suspect-child-autism#new_tab by Katie Cloyd – December 18, 2020 So, you think your young child might be on the autism spectrum. Maybe they’re not talking or communicating as expected, or they don’t seem to understand when you talk to them. Perhaps they seem exceptionally frustrated and their tantrum...
https://www.unite.ai/dennis-wall-phd-co-founder-of-cognoa-interview-series/#new_tab
https://www.aitrends.com/healthcare/startup-cognoa-seeks-fda-approval-for-device-with-ai-to-help-diagnose-autism/#new_tab
https://www.forbes.com/sites/graisondangor/2020/10/06/this-ai-tool-for-diagnosing-autism-could-hit-the-market-in-the-second-half-of-2021/?sh=5665ebde2038#new_tab
https://www.nsmedicaldevices.com/news/diagnosing-autism-in-children-cognoa/##new_tab US firm Cognoa is targeting FDA approval for its AI-based smartphone app – which aims to improve the current approach to diagnosing autism in children By Jamie Bell A new digital method for diagnosing autism in children may be set for FDA clearance...
https://www.fiercebiotech.com/medtech/cognoa-s-ai-powered-diagnostic-app-for-autism-clears-clinical-study-heads-for-fda-review#new_tab by Conor Hale Cognoa aims to equip primary care pediatricians with an artificial-intelligence-powered digital app that can spot the signs of autism, allowing them to rule out or diagnose spectrum disorders within the doctor’s office or remotely. This could represent a broad shift in...
https://spectrum.ieee.org/cognoa-ai-autism-diagnostic-seeks-fda-clearance#new_tab The startup Cognoa has submitted its app-based tool for FDA clearance By Megan Scudellari This week, a California-based company announced it will seek FDA clearance for a first-of-its-kind autism spectrum disorder (ASD) diagnostic tool. Cognoa’s technology uses artificial intelligence to make an ASD diagnosis within weeks of signs...
https://www.globenewswire.com/en/news-release/2020/09/23/2098045/0/en/Cognoa-Seeks-FDA-Clearance-for-Breakthrough-Digital-Autism-Diagnostic-Device-After-Successful-Pivotal-Study.htmlCognoa’s autism diagnostic device is positioned to be the first FDA-cleared digital solution enabling pediatricians to diagnose autism – a paradigm shift in the standard of care (Palo Alto, Calif. – September 23, 2020) – Cognoa, the leading pediatric behavioral health company developing diagnostic...
https://www.parents.com/parenting/dynamics/single-parenting/shouldering-the-mental-load-on-your-own/ Single parents often carry the pressures of parenting on their own and burnout comes hard and fast. Relief does exist in the form of a support village—here’s what to know and how to create yours. By Adrienne Farr Parenting is tough. Worrying about finances,...
https://www.scarymommy.com/prepare-kids-transition-out-of-lockdown by Elaine Roth There was no preparation for the transition into lockdown. One day, COVID-19 was a vague virus I was reading about in the news, and the next, it was here—in my small town, in my schools. And everything shut down with alarming speed....
https://medcitynews.com/2020/05/how-ai-can-overcome-gender-bias-in-autism-diagnosis-and-treatment/?rf=1#new_tab Researchers and advocates have convincingly shown that the wide gap in diagnoses between boys and girls isn’t simply a matter of boys being significantly more likely to be on the autism spectrum. By DAVID HAPPEL Statistically, boys are four times as likely as girls to receive...
https://www.autismparentingmagazine.com/coronavirus-and-autism/#new_tab Even as households worldwide self-isolate to help curb the spread of the novel coronavirus, we’re the furthest thing from isolated when it comes to what we’re experiencing—starting from the shared stress and concern we’re feeling amid such significant upheaval and uncertainty. For families with a...
https://www.globenewswire.com/en/news-release/2020/03/24/2005312/0/en/Cognoa-Appoints-Industry-Leader-David-Happel-as-New-Chief-Executive-Officer.htmlHappel takes up the top job at Cognoa after over 25 years of successfully commercializing medical products and as a leader in the biotech and biopharma industries. (Palo Alto, Calif. – March 24, 2020) – Cognoa, the leading digital therapeutics company focused on pediatric...
https://www.forbes.com/sites/cognitiveworld/2020/03/19/can-ai-help-with-autism-diagnosis/?sh=7a914cf764a3#42ed3bcc64a3#new_tab An Interview with Cognoa’s CEO Brent Vaughan In the US, one in five children are living with a diagnosable behavioral health disorder; however, only 21% of those children who are diagnosed receive needed treatment. Often, parents have to wait one to three years to receive a proper...
Halim Abbas, Ford Garberson, Stuart Liu-Mayo, Eric Glover & Dennis P. Wall Scientific Reports volume 10, Article number: 5014 (2020) Cite this article 2 Altmetric | Metricsdetails Abstract Autism has become a pressing healthcare challenge. The instruments used to aid diagnosis are time and labor expensive and require trained clinicians to administer, leading to long wait...
https://www.forbes.com/sites/forbesbooksauthors/2020/03/12/how-ai-can-transform-the-autism-services-industry/?sh=778224d867ac#24e4cf8567ac#new_tab Ronit Molko, Ph.D., BCBA-D describes how AI will become the norm of autism services, as it has in other industries, including Cognoa’s digital therapeutics that create a more proactive role for parents and pediatricians in the diagnostic and treatment processes to accomplish early...
https://www.globenewswire.com/en/news-release/2020/03/05/1995917/0/en/Cognoa-Appoints-Dr-Colleen-Kraft-Senior-Medical-Director-of-Clinical-Adoption.htmlAAP 2018 Past President Joins Cognoa to Improve the Standard of Care for Children with Autism Through Greater Pediatrician Adoption of Digital Prescription Apps (Palo Alto, Calif.– March 5, 2020) – Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today...
https://www.globenewswire.com/en/news-release/2020/02/26/1991052/0/en/Cognoa-CEO-to-Participate-in-the-Cowen-and-Company-40th-Annual-Healthcare-Conference.htmlPALO ALTO, Calif. — February 26, 2020 — Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that CEO, Brent Vaughan, will participate in a digital therapeutics panel discussion at the Cowen and Company 40th Annual Healthcare Conference with executives...
https://www.fiercebiotech.com/medtech/cognoa-teams-up-autism-learning-partners-to-distribute-its-smartphone-screening-app#new_tab Pediatric digital therapeutics developer Cognoa has teamed up with Autism Learning Partners, a specialized treatment provider, to put its autism screening app in the hands of parents to help track their children’s development. Read the full article here.
https://www.globenewswire.com/en/news-release/2020/02/11/1983107/0/en/Autism-Learning-Partners-and-Cognoa-Announce-Partnership-to-Enable-Earlier-Access-to-Care.htmlPASADENA and PALO ALTO, Calif. – February 11, 2020 – Autism Learning Partners (“ALP”), a national leader in the treatment of autism and other developmental disabilities, and Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today a partnership designed to...
https://www.globenewswire.com/en/news-release/2020/02/10/1982378/0/en/Cognoa-Executives-to-Speak-at-DTx-West-2020.htmlPALO ALTO, Calif. — February 10, 2020 — Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that three company executives will be on stage at the third annual DTx West 2020, taking place in San Mateo, California, February 18...
https://www.globenewswire.com/en/news-release/2020/01/29/1976820/0/en/Cognoa-Named-to-the-2020-Global-Digital-Health-100-By-The-Journal-of-mHealth.htmlInternational Health Technology Publication Annual List Recognizes Innovation and Leaders in Health Technology Palo Alto, Calif., and London – January 29, 2020 – Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, has been named to the 2020 Global Digital Health 100...
https://medcitynews.com/2020/01/digital-therapeutics-can-solve-the-greatest-unmet-need-in-behavioral-healthcare-early-intervention/?rf=1#new_tab Cognoa CMO, Sharief Taraman, MD, DABPN, DABPM, FAAP, authored a MedCity News Influencer article about the potential of digital therapeutics and ai to empower pediatricians and make early intervention possible for more children. Our mental and behavioral health is largely determined by how...
https://www.globenewswire.com/en/news-release/2020/01/06/1966474/0/en/Cognoa-CEO-and-CMO-Presenting-at-Digital-Medicine-Medtech-Showcase-2020-and-InnovatorMD-Global-Summit-in-San-Francisco.htmlPALO ALTO, Calif.- January 6, 2020—Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that senior executives will be speaking at two healthcare innovation and investor conferences in San Francisco. ● Brent Vaughan, CEO and co-founder of Cognoa, will provide...
https://www.globenewswire.com/en/news-release/2019/12/18/1962445/0/en/Cognoa-Wins-2019-Fierce-Innovation-Life-Science-Award.html Palo Alto, Calif., December 18, 2019 – Cognoa, a company at the forefront of pediatric behavioral health, has won the Fierce Innovation Life Science Award for Technology Innovation. Cognoa’s digital therapeutics will advance the standard of care by giving every child the opportunity...
https://elemental.medium.com/newly-expanded-recommendations-on-autism-seek-to-catch-more-kids-who-might-fall-through-the-cracks-5a7e1db50c7a#new_tab WRITTEN BY Shannon Ashley The American Academy of Pediatrics (AAP) recommends that all children get screened for autism spectrum disorder at their 18- and 24-month well-child checkups. Today, those recommendations have been significantly enhanced. These new guidelines now recommend developmental and behavioral surveillance at 9-,...
https://www.bloomberg.com/press-releases/2019-12-05/cognoa-selected-as-finalist-in-fierce-innovation-awards-life-sciences-edition-2019Cognoa develops AI-powered digital therapeutics and medicines that advance the standard of care in pediatric behavioral health and improve lifelong outcomes for children Palo Alto, Calif., December 5, 2019 – Cognoa, a company at the forefront of pediatric behavioral health, announced today that it...
Rosmary Ros‐Demarize, Catherine Bradley, Stephen M. Kanne, Zachary Warren, Andrea Boan, Clara Lajonchere, Justine Park, Laura Arnstein Carpenter Abstract Although considerable work has documented higher prevalence rates of autism spectrum disorder (ASD) in boys, fewer studies have focused on sex differences within samples of young children...
https://www.globenewswire.com/news-release/2019/11/14/1947500/0/en/COGNOA-TO-PARTICIPATE-IN-BTIG-DIGITAL-HEALTH-AND-EVERCORE-ISI-HealthCONx-CONFERENCES.htmlPalo Alto, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of pediatric behavioral health, announced today that CEO Brent Vaughan will be speaking at two upcoming investor conferences: BTIG Digital Health 2019: Industry Innovators on What’s Next. Panel entitled, “Developing Commercial...
By Brent Vaughan, CEO and Co-Founder, Cognoa. We are experiencing a mental health crisis:one person in every four in the world will develop one or more behavioral conditions during their lifetime. Today in the U.S., one in five children have a diagnosable behavioral health disorder...
https://www.globenewswire.com/news-release/2019/10/28/1936418/0/en/Cognoa-CEO-Brent-Vaughan-to-Speak-at-HLTH-and-CNS-Summit.htmlPalo Alto, Calif. and Orlando, Oct. 28, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of pediatric behavioral health, announced today that CEO Brent Vaughan will be speaking about the future of digital therapeutics at two conferences this week, HLTH and CNS Summit....
https://www.globenewswire.com/news-release/2019/10/24/1935017/0/en/Cognoa-Launches-Pivotal-Study-of-the-First-Digital-Diagnostic-for-Autism.htmlPalo Alto, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of pediatric behavioral health, announced today initiation of its Pivotal Study to demonstrate the effectiveness of its diagnostic aid for autism spectrum disorder (ASD). The company anticipates submitting the results...
https://medcitynews.com/2019/09/presentation-highlights-challenges-and-opportunities-in-digital-therapeutics-clinical-trials/?rf=1https://medcitynews.com/2019/09/presentation-highlights-challenges-and-opportunities-in-digital-therapeutics-clinical-trials/?rf=1#new_tab Digital therapeutics clinical trials enable collection and analysis of data in real time, but considerations like standardization of analysis, trial endpoints and placebo controls are critical, experts at the DTx East conference in Boston said. Read full article here.
https://www.eversana.com/ja/2019/09/10/cognoa-and-eversana-announce-partnership-to-advance-the-commercialization-standard-for-prescription-digital-medicines/PALO ALTO, Calif. and CHICAGO, Sept. 10, 2019 /PRNewswire/ — Cognoa, a company at the forefront of pediatric behavioral health, and EVERSANA™, the leading independent provider of global commercial services to the life science industry, today announced a partnership to advance the industry standard by which digital medicines will be...
Du Y1,2, Abbas H2, Taraman S1,2,3, Segar S2, Bischoff N2. Author information 1University of California, Irvine, CA, USA.2Cognoa Inc., Palo Alto, CA, USA.3Children’s Hospital of Orange County, Orange, CA, USA. Abstract Early identification and intervention of speech and language delays in children contribute to better communication and literacy...
https://www.globenewswire.com/en/news-release/2019/04/10/1802043/0/en/Cognoa-Licenses-Innovative-Digital-Therapeutic-Technology.htmlPALO ALTO, Calif., April 10, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of digital behavioral health for children, today announces it has exclusively licensed technology from the Stanford University School of Medicine to accelerate development and worldwide commercialization of a novel digital...
Journal of Autism and Developmental Disorders. Abstract Differential diagnosis of autism spectrum disorder (ASD) is challenging, and uncertainty regarding a child’s diagnosis may result in under-identification or prolonged diagnostic pathways. The current study examined diagnostic certainty, or how sure clinicians were that their diagnosis...
JAMA Pediatr. 2019;173(5):446-454. doi:10.1001/jamapediatrics.2019.0285 Catalin Voss, MS1; Jessey Schwartz, BA2; Jena Daniels, BS2; et al Abstract Importance Autism behavioral therapy is effective but expensive and difficult to access. While mobile technology–based therapy can alleviate wait-lists and scale for increasing demand, few clinical trials exist to support its use for autism spectrum disorder (ASD) care. Objective To...
Cognoa Receives FDA Breakthrough Designations for Autism Diagnostic and Digital Therapeutic Devices.
https://www.globenewswire.com/news-release/2019/02/06/1711471/0/en/Cognoa-Receives-FDA-Breakthrough-Designations-for-Autism-Diagnostic-and-Digital-Therapeutic-Devices.htmlPALO ALTO, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of digital behavioral health for children, today announces it has received Breakthrough Device designations from the U.S. Food and Drug Administration (FDA) for its lead products, the first digital diagnostic...
https://www.globenewswire.com/news-release/2019/01/08/1682126/0/en/Cognoa-Selected-by-Cambia-Health-Solutions-to-Provide-Support-for-Employees-Raising-Young-Children.html Email Print Friendly ShareJanuary 08, 2019 09:03 ET | Source: Cognoa PALO ALTO, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) — Cognoa, a digital behavioral health company, announced today that Cambia Health Solutions, Inc. (Cambia) is incorporating Cognoa’s evidence-based platform within its subsidiary health plans. Cognoa provides support for employees caring...
Plos Medicine. Published: November 27, 2018. Abstract Background The standard approaches to diagnosing autism spectrum disorder (ASD) evaluate between 20 and 100 behaviors and take several hours to complete. This has in part contributed to long wait times for a diagnosis and subsequent delays...
https://www.globenewswire.com/news-release/2018/08/27/1557135/0/en/Cognoa-Demonstrates-Advances-of-its-AI-Based-Technology-for-Identifying-Autism-in-Children.htmlPALO ALTO, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) — Cognoa, a digital behavioral health company, today announces results from a clinical study of its second-generation AI based algorithms which demonstrates accuracy improvements over its first-generation screening algorithm in supporting the diagnosis of autism spectrum...
npj Digital Medicine. Published: 02 August 2018. Abstract Although standard behavioral interventions for autism spectrum disorder (ASD) are effective therapies for social deficits, they face criticism for being time-intensive and overdependent on specialists. Earlier starting age of therapy is a strong predictor of later success,...
https://www.globenewswire.com/news-release/2018/06/12/1520417/0/en/SAP-Teams-with-Cognoa-to-Bridge-Gap-in-Healthcare-for-Employees-Raising-Young-Children.htmlPALO ALTO, Calif., June 12, 2018 (GLOBE NEWSWIRE) — Cognoa, a digital behavioral health company, today announces its partnership with SAP, a market leader in enterprise application software. More than 19,000 SAP employees in North America will now have access to Cognoa’s app to help their...
Wiley Online Library. Abstract There are many available tools with varying levels of accuracy designed to screen for Autism Spectrum Disorder (ASD) in young children, both in the general population and specifically among those referred for developmental concerns. With burgeoning waitlists for comprehensive diagnostic...
JAMIA. Abstract Background Existing screening tools for early detection of autism are expensive, cumbersome, time- intensive, and sometimes fall short in predictive value. In this work, we sought to apply Machine Learning (ML) to gold standard clinical data obtained across thousands of children at-risk...
https://www.globenewswire.com/news-release/2018/02/21/1372689/0/en/Cognoa-Hits-Major-Milestone-Towards-First-AI-Based-Autism-Diagnostic.html/PALO ALTO, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) — Cognoa, a company offering an AI-based platform for pediatric behavioral health diagnostics and digital therapeutics, announces that the U.S. Food and Drug Administration (FDA) has established that Cognoa’s software is a Class II diagnostic medical...
Molecular Autism. Abstract Background Autism spectrum disorder (ASD) diagnosis can be delayed due in part to the time required for administration of standard exams, such as the Autism Diagnostic Observation Schedule (ADOS). Shorter and potentially mobilized approaches would help to alleviate bottlenecks in the...
2017 IEEE International Conference on Big Data. Abstract Existing screening tools for early detection of autism are expensive, cumbersome, time-intensive, and sometimes fall short in predictive value. In this work, we apply Machine Learning to gold standard clinical data obtained across thousands of children...
https://www.prnewswire.com/news-releases/cognoa-announces-leadership-expansion-with-strategic-hires-301840253.htmlPALO ALTO, CA–(Marketwired – Jun 14, 2017) – Cognoa, a digital health company revolutionizing how children with developmental delays are diagnosed and supported, today announces Sharief Taraman, MD as its vice president of medical and clinical. Dr. Taraman will lead the company’s further clinical validation...
Translational Psychiatry. Abstract Autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) together affect >10% of the children in the United States, but considerable behavioral overlaps between the two disorders can often complicate differential diagnosis. Currently, there is no screening test designed to...
Journal of Autism and Developmental Disorders. Abstract The Mobile Autism Risk Assessment (MARA) is a new, electronically administered, 7-question autism spectrum disorder (ASD) screen to triage those at highest risk for ASD. Children 16 months–17 years (N = 222) were screened during their first visit in a developmental-behavioral...
In Proceedings of the 2016 CHI Conference Extended Abstracts on Human Factors in Computing Systems. Abstract Over 1 million children under the age of 17 in the US have been identified with Autism Spectrum Disorder (ASD). These children struggle to recognize facial expressions, make...
Translational Psychiatry volume 6, page 732(2016) M Duda, R Ma, N Haber & D P Wall Abstract Although autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) continue to rise in prevalence, together affecting >10% of today’s pediatric population, the methods of diagnosis remain subjective, cumbersome and time intensive. With...
Translational Psychiatry. Abstract Although the prevalence of autism spectrum disorder (ASD) has risen sharply in the last few years reaching 1 in 68, the average age of diagnosis in the United States remains close to 4—well past the developmental window when early intervention has...
PLOS ONE. Abstract The Autism Diagnostic Interview-Revised (ADI-R) is one of the most commonly used instruments for assisting in the behavioral diagnosis of autism. The exam consists of 93 questions that must be answered by a care provider within a focused session that often...
Translational Psychiatry. Abstract The Autism Diagnostic Observation Schedule-Generic (ADOS) is one of the most widely used instruments for behavioral evaluation of autism spectrum disorders. It is composed of four modules, each tailored for a specific group of individuals based on their language and developmental...